Eli Lilly Shares Outstanding 2006-2018 | LLY

Eli Lilly shares outstanding history from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Eli Lilly shares outstanding for the quarter ending September 30, 2018 were 1.026B, a 2.81% decline year-over-year.
  • Eli Lilly 2017 shares outstanding were 1.052B, a 0.92% decline from 2016.
  • Eli Lilly 2016 shares outstanding were 1.062B, a 0.37% decline from 2015.
  • Eli Lilly 2015 shares outstanding were 1.066B, a 0.8% decline from 2014.
Eli Lilly Annual Shares Outstanding
(Millions of Shares)
2017 1,052
2016 1,062
2015 1,066
2014 1,074
2013 1,085
2012 1,117
2011 1,114
2010 1,106
2009 1,098
2008 1,094
2007 1,091
2006 1,087
2005 1,092
Eli Lilly Quarterly Shares Outstanding
(Millions of Shares)
Q3 2018 1,026
Q2 2018 1,030
Q1 2018 1,050
Q4 2017 1,052
Q3 2017 1,056
Q2 2017 1,057
Q1 2017 1,056
Q4 2016 1,062
Q3 2016 1,061
Q2 2016 1,060
Q1 2016 1,063
Q4 2015 1,066
Q3 2015 1,065
Q2 2015 1,066
Q1 2015 1,067
Q4 2014 1,074
Q3 2014 1,074
Q2 2014 1,076
Q1 2014 1,076
Q4 2013 1,085
Q3 2013 1,084
Q2 2013 1,084
Q1 2013 1,092
Q4 2012 1,117
Q3 2012 1,120
Q2 2012 1,119
Q1 2012 1,110
Q4 2011 1,114
Q3 2011 1,114
Q2 2011 1,114
Q1 2011 1,112
Q4 2010 1,106
Q3 2010 1,105
Q2 2010 1,104
Q1 2010 1,103
Q4 2009 1,098
Q3 2009 1,098
Q2 2009 1,097
Q1 2009 1,097
Q4 2008 1,094
Q3 2008 1,094
Q2 2008 1,094
Q1 2008 1,094
Q4 2007 1,091
Q3 2007 1,090
Q2 2007 1,090
Q1 2007 1,090
Q4 2006 1,087
Q3 2006 1,086
Q2 2006 1,085
Q1 2006 1,087
Q4 2005 1,092
Q3 2005 1,091
Q2 2005 1,088
Q1 2005 1,089
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $120.583B $22.871B
Eli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. They were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and they remain true to that mission in all their work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $391.677B 18.36
Pfizer (PFE) United States $259.009B 14.60
Merck (MRK) United States $205.072B 17.77
Novartis AG (NVS) Switzerland $203.357B 17.38
AbbVie (ABBV) United States $137.681B 12.22
Sanofi (SNY) France $113.115B 14.01
Novo Nordisk (NVO) Denmark $107.931B 17.53
AstraZeneca (AZN) United Kingdom $103.013B 12.79
GlaxoSmithKline (GSK) United Kingdom $100.041B 13.45
Bristol-Myers Squibb (BMY) United States $88.253B 14.53